The Fund aims to provide long term total returns primarily through investment in the shares of companies around the world. Investments will largely be determined by the application of a contrarian investment process and will be in a selection of companies which will not be restricted either by size, industry, or geographical location.
Name | % Net Assets |
---|---|
Pfizer Inc. | 2.4% |
Medtronic Inc. | 2.4% |
Lagardere Groupe | 2.3% |
SK Telecom Co. | 2.2% |
Glaxosmithkline | 2.1% |
NTT Docomo Inc. | 2.1% |
Yamaha Corp | 2.1% |
Helical Bar Plc | 1.9% |
ENI S.P.A. | 1.9% |
Merck & Co Inc. | 1.8% |
Key | % Net Assets |
---|---|
![]() |
2.4% |
![]() |
2.4% |
![]() |
2.3% |
![]() |
2.2% |
![]() |
90.7% |
Date | 25-Apr-2025 |
---|---|
NAV | 430.35p |
Currency | GBP |
Change | 6.65p |
% | 1.57% |
YTD change | -9.26p |
YTD % | -2.11% |
Fund Inception | 17/12/2007 |
---|---|
Fund Manager | n/a |
TER | - |
Minimum Investment | |
---|---|
Initial | £1000000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research